IGAIN (Instituto Global de Atención Integral al Neurodesarrollo)

Barcelona 08007

0 studies enrolling now · 1 studies all time

What they study most

Autism Spectrum Disorder (ASD)

Studies at this site

• A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) — Completed